kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 150mg - sarilumab 150mg - disease-modifying antirheumatic agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 200mg - sarilumab 200mg - disease-modifying antirheumatic agents
dupixent solution
sanofi-aventis canada inc - dupilumab - solution - 300mg - dupilumab 300mg - misc. skin and mucous membrane agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 150mg - sarilumab 150mg - disease-modifying antirheumatic agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 200mg - sarilumab 200mg - disease-modifying antirheumatic agents
dupixent solution
sanofi-aventis canada inc - dupilumab - solution - 200mg - dupilumab 200mg - misc. skin and mucous membrane agents
dupixent solution
sanofi-aventis canada inc - dupilumab - solution - 300mg - dupilumab 300mg - misc. skin and mucous membrane agents
dupixent solution
sanofi-aventis canada inc - dupilumab - solution - 200mg - dupilumab 200mg
dupixent solution
sanofi-aventis canada inc - dupilumab - solution - 100mg - dupilumab 100mg
solystat poudre pour suspension
pendopharm division of pharmascience inc - polystyrène sulfonate de sodium - poudre pour suspension - 1g - polystyrène sulfonate de sodium 1g - potassium-removing agents